Quantification of Eicosanoids and Their Metabolites in Biological Matrices: a Review
Overview
Affiliations
The quantification of eicosanoids and their metabolites in biological samples remain an analytical challenge, even though a number of methodologies/techniques have been developed. The major difficulties encountered are related to the oxidation of eicosanoids and their low quantities in biological matrices. Among the known methodologies, liquid chromatography-mass spectrometry (LC-MS/MS) is the standard method for eicosanoid quantification in biological samples. Recently advances have improved the ability to identify and simultaneous quantitate eicosanoids in biological matrices. The present article reviews the quantitative analysis of eicosanoids in different biological matrices by LC and ultra performance liquid chromatography (UPLC)-MS/MS and discusses important aspects to be considered during the collection, sample preparation and the generation of calibration curves required for eicosanoid analysis.
Liu S, Zhao F, Zhang Y, Sun X, Zhang M, Hou K Se Pu. 2025; 43(2):148-154.
PMID: 39844705 PMC: 11755747. DOI: 10.3724/SP.J.1123.2024.02004.
Revol-Cavalier J, Quaranta A, Newman J, Brash A, Hamberg M, Wheelock C Chem Rev. 2024; 125(1):1-90.
PMID: 39680864 PMC: 11719350. DOI: 10.1021/acs.chemrev.3c00520.
Pharmaceutical Modulation of Intracranial Aneurysm Development and Rupture.
Crane A, Shanahan R, Hudson J, Nowicki K, Gersey Z, Agarwal P J Clin Med. 2024; 13(11).
PMID: 38893035 PMC: 11173282. DOI: 10.3390/jcm13113324.
Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease.
Geurts F, Chaker L, van der Burgh A, Cronin-Fenton D, Fenton R, Hoorn E J Am Heart Assoc. 2024; 13(4):e032835.
PMID: 38362883 PMC: 11010119. DOI: 10.1161/JAHA.123.032835.
Impact of Selected Eicosanoids in Normal and Pathological Pregnancies.
Szczuko M, Golanska J, Palma J, Zietek M J Clin Med. 2023; 12(18).
PMID: 37762934 PMC: 10532391. DOI: 10.3390/jcm12185995.